Trials / Not Yet Recruiting
Not Yet RecruitingNCT06399172
OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
OncoSil Pancreatic Cancer Post-marketing Clinical Registry Italy
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- OncoSil Medical Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The OSPRItaly Patient Registry has been developed to assess the performance and safety of the OncoSil™ device when used within the approved indication of unresectable, locally advanced pancreatic cancer, in combination with gemcitabine-based chemotherapy, within a real-world observational registry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OncoSil | Intra-tumoural implantation |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2029-05-30
- Completion
- 2029-10-30
- First posted
- 2024-05-03
- Last updated
- 2024-05-03
Source: ClinicalTrials.gov record NCT06399172. Inclusion in this directory is not an endorsement.